MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/ijp.ijp_673_21

Медицинская библиотека · Indian journal of pharmacology · 2023

Efficacy and safety of levamisole in childhood nephrotic syndrome: A meta-analysis.

Bhatt Girish Chandra, Patel Bhupeshwari, Das Rashmi Ranjan, Malik Shikha, Bitzan Martin, Mishra Nihar Ranjan

МетаанализСтатьяОбзорПеревод в очереди

Аннотация

Present evidence regarding the efficacy and safety of levamisole in childhood nephrotic syndrome (NS), particularly the steroid-sensitive NS (SSNS), is limited. We searched relevant databases such as PubMed/MEDLINE, Embase, Google Scholar, and Cochrane CENTRAL till June 30, 2020. We included 12 studies for evidence synthesis (5 were clinical trials that included 326 children). The proportion of children without relapses at 6-12 months was higher in the levamisole group as compared to steroids (relative risk [RR]: 5.9 [95% Confidence interval (CI): 0.13-264.8], I2 = 85%). Levamisole as compared to the control increased the proportion of children without relapses at 6-12 months (RR: 3.55 [95% CI: 2.19-5.75], I2 = 0%). The GRADE evidence was of "very-low certainty" except for the comparison of levamisole with control, the latter being of "moderate certainty." To conclude, levamisole given to children with SSNS is beneficial in preventing relapses and achieving remission as compared to placebo or low-dose steroids. Good-quality trials are needed to provide a robust evidence in this regard. PROSPERO Registration number: CRD42018086247.

Для цитирования: Bhatt Girish Chandra, Patel Bhupeshwari, Das Rashmi Ranjan, Malik Shikha, Bitzan Martin, Mishra Nihar Ranjan. Efficacy and safety of levamisole in childhood nephrotic syndrome: A meta-analysis.. Indian journal of pharmacology. 2023. DOI: 10.4103/ijp.ijp_673_21.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.